All News

Clinical Trial Watch

This list of U.S.-based clinical trials is derived from the National Institute of Health's database and includes phase III advanced prostate cancer trials that are currently recruiting participants as of Jan. 22, 2010.

Medicare stopped paying for consults on Jan. 1. This article will provide you with our recommendations on how to bill Medicare and private payers based on the changes made by Medicare and our knowledge of payer decisions at the time the article was written.

A new model has been developed to help patients with testicular cancer decide on a treatment option by assisting them in considering life expectancy and quality of life estimates as they make their choice.

An investigational treatment for premature ejaculation, PSD502, appears to delay ejaculation up to five times longer than placebo, according to a study presented at the 2009 Sexual Medicine Society of North America annual meeting in San Diego.

The Centers for Medicare & Medicaid Services and the Office of the National Coordinator for Health Information Technology (ONC) are seeking public comment on two regulations that lay a foundation for improving quality, efficiency, and safety through meaningful use of certified EHR technology, the agencies said.

Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first 2 years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a recently published study.

Submucosal injection of the steroid triamcinolone (Kenalog) is a safe, effective alternative to fulguration or laser ablation for treating Hunner's ulcers in interstitial cystitis patients.

Once again, urologists have had to face the prospects of huge reductions in their Medicare reimbursement rates because of the inability of Congress to resolve the problems imposed by the sustainable growth rate (SGR) formula, and once again, they must count on a temporary reprieve.